Maria Verissimo, MSc,  —

Rare Disease Day 2023

Recent Posts

• EasyM, blood test for residual myeloma activity, certified in US
• Fatty acid-binding proteins may be potential target for myeloma
• Prominent voices to help spotlight myeloma risk in Black communities
• Goal of Myeloma Action Month? Telling the community’s stories.
• Elranatamab under FDA priority review for hard-to-treat myeloma